Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT02070393
Eligibility Criteria:
Inclusion Criteria:
* Female sex
* Age \>/= 10 years old and \< 30 years old
* Pathologically confirmed classical Hodgkin's Lymphoma
* At least one site of disease located above the diaphragm
* Signed study-specific consent prior to initiation of therapy
* Women of child-bearing potential must have a negative pregnancy blood test within 7 days of starting protocol therapy.
Exclusion Criteria:
* Previous radiation therapy to any part of the body.
* Parenchymal lung involvement at initial presentation or any patient that may need whole lung irradiation as per institutional guidelines.
* Lymphocyte predominant histology not eligible.
* Significant infection or other coexistent medical condition that would preclude protocol therapy such as:
* History of HIV/AIDS
* History of collagen Vascular Disease
* Symptomatic congestive heart failure
* Unstable angina pectoris or myocardial infarction within 6 months
* Uncontrolled hypertension (systolic blood pressure \> 160 mm Hg or diastolic blood pressure \> 100 mm Hg on 2 consecutive measurements separated by 1 week).
* History of uncontrolled diabetes
* Psychiatric illness/social situations that would compromise patient safety or limit compliance with study requirements
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
10 Years
Maximum Age:
30 Years
Study:
NCT02070393
Study Brief:
Protocol Section:
NCT02070393